Department Home >
- Base >
- You are here
Neuro-Oncology
| Current Neuro-Oncology Trials |
| A Phase II Trial of Talampanel in Conjunction with Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Mulitforme PI: Myrna R. Rosenfield, MD, PhD |
| A Phase II Trial of Radiation plus Temozolomide followed by adjuvant Temozolomide and Poly-ICLC in Patients with Newly Diagnosed Glioblastoma Multiforme PI: Myrna R. Rosenfield, MD, PhD |
| A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant and Adjuvant Temozlomide with Radiation Therapy in PAtients with Newly Diagnosed Glioblastoma Multiforme PI: Myrna R. Rosenfield, MD, PhD |
| A Phase I Evaluation of the Safety of PS-341 in the Treatment of Recurrent Gliomas PI: Myrna R. Rosenfield, MD, PhD |
| A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Gliomas PI: Josep Dalmau, MD, PhD |
| A Phase I/II Trial of BMS-247550 for Treatment of PAtients with Recurrent Malignant Gliomas PI: Josep Dalmau, MD, PhD |
| A Study of Autoimmune Responses in Disorders of the Nervous System PI: Josep Dalmau, MD, PhD |
| Paraneoplastic Disorders of the CNS: Autoantigen Profiling PI: Josep Dalmau, MD, PhD |
| Evaluation of T-Cell Immunity in Patients with Antibody-associated Paraneoplastic Neurologic Disorders PI: Josep Dalmau, MD, PhD |
| Immunity to Brain Ma Proteins: A Remote Effect of Cancers PI: Josep Dalmau, MD, PhD |
